Uptake of 18F-FtRGD in U87-MG (n = 4) and MDA-MB-231 (n = 7) Tumors
| Uptake (mean ± SD %ID/g) of 18F-FtRGD in: | ||||
| U87-MG tumors | MDA-MB-231 tumors | |||
| Days after treatment | Axitinib treated | Vehicle treated | Axitinib treated | Vehicle treated |
| 0 | 1.62 ± 0.32 | 1.50 ± 0.25 | 1.59 ± 0.72 | 1.58 ± 0.41 |
| 1 | 1.66 ± 0.23 | 1.74 ± 0.29 | 1.69 ± 0.17 | 1.71 ± 0.14 |
| 3 | 1.37 ± 0.29 | 1.61 ± 0.43 | 1.07 ± 0.28 | 1.36 ± 0.06 |
| 7 | 1.43 ± 0.22 | 2.40 ± 0.56 | 2.01 ± 0.54 | 1.90 ± 0.59 |
| 10 | 1.65 ± 0.25 | 3.33 ± 0.63 | 1.28 ± 0.06 | 1.50 ± 0.03 |